Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.
Antibodies against β2-glycoprotein I are a subset of very heterogeneous family of antiphospholipid antibodies. It is well recognised that anti-β2-glycoprotein I antibodies are the main pathogenic players in the autoimmune disease known as antiphospholipid syndrome. Many mechanisms have been proposed through which these autoantibodies could cause microplacental, arterial or venous thrombosis. One of the suggested mechanisms is an antiphospholipid antibody-mediated disruption of annexin A5 protective crystalline shield on negatively charged phospholipid membranes. In current report the study of β2-glycoprotein I, anti-β2-glycoprotein I antibodies and annexin A5 interactions was performed on in vitro model of planar solid-supported phospholipid bilayers and visualized by atomic force microscopy. Planar phospholipid bilayers comprised 30 % L-α-phosphatidylserine and 70 % L-α-phosphatidylcholine. For the study of interactions 10 mg/l annexin A5, 0.15 g/l β2-glycoprotein I, 10 g/l of IgG fraction from healthy blood donor, 10 g/l of IgG fraction from a patient with anti-β2-glycoprotein I antibodies and 0.4 g/l of isolated IgG anti-β2-glycoprotein I antibodies from the same patients in Hepes buffered saline with 1.5 mM Ca2+ were used. We confirmed the clustering of β2-glycoprotein I on planar phospholipid bilayers. We also found that in the presence of annexin A5, β2-glycoprotein I does not bind to planar phospholipid bilayers. However, when adding the anti-β2-glycoprotein I antibodies, the growth of β2-glycoprotein I-anti-β2-glycoprotein I antibodies complexes in the presence of incompletely crystallized annexin A5 on planar phospholipid bilayers was observed. Results confirm the possible thrombomodulatory activity of anti-β2-glycoprotein antibodies through their effect on crystalline annexin A5. In addition, the hypothesis that the presence of possibly pathologic antigen-antibody pair itself is not sufficient to start the pathological process is confirmed and visualized for the first time.
University Medical Centre , Division of Internal Medicine, Department of Rheumatology, Vodnikova cesta 61, SI-1000 Ljubljana, Slovenia.
Špela
Š
Irman
Jožef Stefan Institute, Department of Condensed matter physics, Jamova cesta 39, SI-1000 Ljubljana, Slovenia; University in Ljubljana, Faculty of Mathematics and Physics, Jadranska 19, SI-1000 Ljubljana, Slovenia.
Miha
M
Škarabot
Jožef Stefan Institute, Department of Condensed matter physics, Jamova cesta 39, SI-1000 Ljubljana, Slovenia; University in Ljubljana, Faculty of Mathematics and Physics, Jadranska 19, SI-1000 Ljubljana, Slovenia.
Igor
I
Muševič
University Medical Centre , Division of Internal Medicine, Department of Rheumatology, Vodnikova cesta 61, SI-1000 Ljubljana, Slovenia.
Blaž
B
Rozman
University Medical Centre, Division of Internal Medicine, Department of Rheumatology, Vodnikova cesta 61, SI-1000 Ljubljana, Slovenia; University in Ljubljana, Faculty of Pharmacy, Chair for Clinical Biochemistry, Aškerčeva cesta 7, SI-1000 Ljubljana, Slovenia.
Borut
B
Božič
Biochemistry. 1977 Dec 13;16(25):5420-6
72562
Eur J Obstet Gynecol Reprod Biol. 2001 May;96(1):37-50
11311759
EMBO J. 1999 Nov 15;18(22):6228-39
10562535
Haematologica. 2006 Oct;91(10):1360-6
17018385
Clin Chem Lab Med. 2004 Feb;42(2):171-4
15061356
Lupus. 2008 Oct;17(10):922-30
18827057
Circ Res. 2002 Jan 11;90(1):29-37
11786515
J Exp Med. 1994 Feb 1;179(2):457-62
7507506
Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1088-9
6414579
Biophys J. 2005 Nov;89(5):3372-85
16085777
Autoimmun Rev. 2008 Sep;7(8):585-7
18706525
Int Immunol. 1997 Jun;9(6):913-21
9199975
Blood. 2007 Feb 15;109(4):1490-4
17053060
FEBS Lett. 2008 Oct 15;582(23-24):3308-12
18822289
Int Immunol. 2002 Jul;14(7):823-30
12096042
Blood. 2006 Mar 1;107(5):1916-24
16269621
EMBO J. 1999 Oct 1;18(19):5166-74
10508150
Lupus. 2003;12(1):37-45
12587825
Biol Chem. 1997 Mar-Apr;378(3-4):177-83
9165068
Am J Pathol. 2003 Sep;163(3):1193-200
12937161
J Immunol. 1995 Jan 15;154(2):954-60
7814895
Biol Reprod. 2001 Dec;65(6):1766-70
11717139
J Immunol. 1995 Aug 1;155(3):1629-36
7543528
EMBO J. 1990 Dec;9(12):3867-74
2147412
Biochem J. 2005 Aug 1;389(Pt 3):665-73
15813706
J Struct Biol. 2000 Sep;131(3):234-9
11052896
J Struct Biol. 1998;121(3):356-61
9705879
Biochemistry. 2000 Feb 29;39(8):1982-9
10684648
J Clin Immunol. 2003 Sep;23(5):377-83
14601646
Baillieres Clin Haematol. 1993 Sep;6(3):691-709
8025348
Clin Exp Immunol. 2000 Jun;120(3):537-43
10844535
J Struct Biol. 2001 Jan;133(1):55-63
11356064
J Autoimmun. 2011 Mar;36(2):98-105
21185149
Autoimmun Rev. 2007 Sep;6(8):547-52
17854747
Autoimmun Rev. 2009 Sep;9(1):5-10
19232551
Ann Rheum Dis. 2004 Nov;63(11):1478-82
15479898
Biochemistry. 2007 Sep 18;46(37):10612-20
17715943
J Thromb Haemost. 2006 Jul;4(7):1619-21
16839363
Biochemistry. 1996 Oct 29;35(43):13833-42
8901526
J Thromb Haemost. 2006 Feb;4(2):295-306
16420554
J Thromb Haemost. 2003 May;1(5):931-42
12871358
Lupus. 2008 Oct;17(10):937-42
18827059
J Immunol. 1998 Apr 15;160(8):3917-23
9558098
Biochim Biophys Acta. 2008 Jun;1783(6):953-63
18334229
Arthritis Rheum. 2007 Jan;56(1):280-90
17195232
Blood. 1998 Sep 1;92(5):1652-60
9716593
J Biol Chem. 2005 Feb 18;280(7):6028-35
15576370
Am J Reprod Immunol. 2003 Sep;50(3):202-8
14629024
Autoimmunity. 2009 Aug;42(5):414-23
19811258
Thromb Res. 2004;114(5-6):335-46
15507263
Int Arch Allergy Immunol. 1997 Jan;112(1):19-26
8980460
Blood. 2010 Aug 26;116(8):1336-43
20462962
Thromb Haemost. 2002 Apr;87(4):599-605
12008941
Rheumatology (Oxford). 2007 Jan;46(1):81-6
16820381
Arthritis Rheum. 1999 Jul;42(7):1309-11
10403256